Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer [Phase 4]
A Phase 4 clinical trial evaluating the effect of zoledronic acid on circulating and bone marrow–residing prostate cancer cells in men with …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer [Phase 2]
This update reports the results of a Phase 2 trial evaluating sequencing of sipuleucel-T immunotherapy and androgen deprivation therapy in m…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss [Phase 3]
Phase 3 trial evaluating whether denosumab for bone loss in men with non-metastatic prostate cancer is associated with new or worsening lens…
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Economic Analyses of the REDUCE Trial
This document reports economic analyses based on the REDUCE trial, evaluating the cost-effectiveness and economic impact of dutasteride in m…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Experiences With HDR-brachytherapy in Norway
This completed clinical trial update from Oslo University Hospital reports experiences with high-dose-rate brachytherapy for prostate cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase II study evaluating DCVAC/PCa added to standard chemotherapy for metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer [Phase 2]
Phase 2 study update on DCVAC for localized prostate cancer discusses allowing a second treatment cycle; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer [Phase 2]
Phase II trial of the DCVAC/PCa dendritic cell vaccine added to hormone therapy in men with metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 trial evaluating pazopanib hydrochloride with or without bicalutamide in hormone-refractory prostate cancer has completed; results w…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer [Phase 2]
A Phase II trial update reports the completion of a study evaluating DCVAC/PCa added after radical prostatectomy for localized prostate canc…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients [Phase 1]
A Phase 1 clinical trial update for the PET/CT imaging agent 68Ga-NOTA-RM26 in patients with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients
A completed clinical trial comparing Ga-68-NODAGA-MJ9 PET/CT with F-18-FCH PET/CT for imaging in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Korean Practice Patterns for Screening PCA(Prostate Cancer)
This completed clinical trial update covers a study on Korean practice patterns for screening prostate cancer, sponsored by GlaxoSmithKline,…
-
FDA approval · 2017-05-19FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for leuprolide acetate from Sandoz Inc, authorizing an update related to this product.
-
FDA label_change · 2017-05-19FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Leuprolide acetate from Sun Pharmaceutical Industries, updating the labeling for this generi…
-
FDA approval · 2017-05-19FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc)
FDA approved a supplemental application for leuprolide acetate from Meitheal Pharmaceuticals Inc, related to the existing approval for this …
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer [NA]
A pilot trial evaluating interpersonal psychotherapy for depression in patients with prostate, colorectal, lung, and pancreatic cancer was t…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: DNA Changes in Patients With Prostate Cancer
An ECOG-ACRIN study evaluating DNA changes in patients with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Soy Protein/Effexor Hormone Therapy for Prostate Cancer [Phase 3]
A Phase 3 trial investigating soy protein combined with Effexor hormone therapy for hot flashes in prostate cancer patients was terminated, …
-
CLINICAL_TRIALS research · 2017-05-18Clinical Trial Update: Digital Rectal Exam Proficiency Tool
An update on a University of Virginia-sponsored clinical trial evaluating a digital rectal exam proficiency tool, related to benign prostati…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer [Phase 1]
Phase I study evaluating panobinostat (LBH589) in combination with external beam radiotherapy for prostate cancer, esophageal cancer, and he…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802
This is a completed clinical trial update reporting PSA antibody levels in samples from patients with prostate cancer treated under ECOG-E98…
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
The document reports on the completion of the ECOG-E5803 study, which collected tissue and blood samples from patients with recurrent prosta…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer [Phase 2]
Phase 2 trial evaluating docetaxel with radiation therapy and prednisone in patients who had undergone surgery for prostate cancer was termi…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study evaluating Calcitriol with Ketoconazole and hydrocortisone for prostate cancer; the study was ter…